Pure Global
NCT06305195

Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome

Potential Correlation Between Heart Rate Variability With Cardiovascular Risk at Different Stages of Metabolic Syndrome: Impact of Some Antidiabetic Drugs
Alexandria University·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Diabetes Mellitus
Drug/Device/Intervention
heart rate variability test
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Alexandria University
Location
Alexandria, Egypt
Timeline & enrollment
Phase
N/A
Start date
Aug 23, 2023
End date
Oct 21, 2026
Enrollment
155 participants
Primary outcome

Beat-to-beat Heart rate variability,body mass index,Valsalva ratio,Stand 30:15 ratio,deep breath test interpretation

Summary

The study aims to assess the beat-to-beat Heart rate variability (HRV) in different stages of
 metabolic diseases, including pre-diabetic and diabetic patients, compared to non-diabetic
 individuals.
 
 Heart rate variability will be compared for some antidiabetic drugs used in different stages
 of metabolic diseases and correlated to different metabolic and inflammatory mediators.

ICD-10 classifications
Diabetes mellitusUnspecified diabetes mellitusOther specified diabetes mellitusUnspecified diabetes mellitus without complicationsUnspecified diabetes mellitus with unspecified complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06305195
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06305195 through Pure Global AI's free database. This phase not specified trial is sponsored by Alexandria University and is currently Recruiting. The study focuses on Diabetes Mellitus. Target enrollment is 155 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.